Companies /Healthcare

Johnson & Johnson

NYSE: JNJ Drug Manufacturers - General
$270.22
▲ $2.94 (+1.10%) today
Markets closed · 4:02am ET

JNJ Coverage

Page 54
10:50am ET
Health and Healthcare

New Crohn’s Disease Drug Approved by FDA

A unit of Johnson & Johnson has announced that the FDA has approved its Stelara for the treatment of moderately to severely active Crohn's disease.

JNJ
Jon C. Ogg
4:01pm ET
Investing

Apple, J&J Weigh on DJIA Monday

August 22, 2016: Markets opened lower again Monday as investors remain cautious ahead of the Fed’s Jackson Hole conference beginning Thursday. Fed Chairwoman Janet Yellen is scheduled to speak on Friday and…

Paul Ausick
4:01pm ET
Investing

McDonald’s, J&J Buoy DJIA on Tuesday

July 19, 2016: Markets opened mixed on Tuesday with the blue chips opening lower before bouncing higher. Unlike the S&P 500 Index and the Nasdaq Composite, which never traded higher at any…

Paul Ausick